Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Physiologic responses to long-term ventilation.

Katherine Hendra1, Bartolome Celli

  • 1Division of Pulmonary and Critical Care, Tufts University School of Medicine, St. Elizabeths Medical Center, 736 Cambridge Street, Boston, MA 02135, USA. khendra@cchcs.org

Respiratory Care Clinics of North America
|December 17, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials.

Lancet (London, England)·2026
Same author

New approaches to uncover COPD pathobiology and develop therapies.

JCI insight·2026
Same author

Corrigendum to "Disease burden and health-related outcomes of patients discharged from hospital following a COPD exacerbation in the United States" [Respir. Med. 248 (2025) 108337].

Respiratory medicine·2025
Same author

Maternal smoking and CC-16: implications for lung development and COPD across the lifespan.

American journal of respiratory and critical care medicine·2025
Same author

Disease burden and health-related outcomes of patients discharged from hospital following a COPD exacerbation in the United States.

Respiratory medicine·2025
Same author

The global burden of COPD: epidemiology and effect of prevention strategies.

The Lancet. Respiratory medicine·2025

Long-term mechanical ventilation (MV) can positively impact respiratory physiology, improving exercise tolerance and cardiac function in select patients. However, it may not alter disease progression or prognosis for those with fibrotic lung disease or COPD.

Area of Science:

  • Pulmonology
  • Critical Care Medicine
  • Respiratory Physiology

Background:

  • Long-term mechanical ventilation (MV) is crucial for patients with restrictive, neuromuscular, or severe obstructive hypercapnic respiratory failure.
  • The impact of MV on respiratory physiology, while often favorable, can be unpredictable.

Purpose of the Study:

  • To evaluate the physiological effects and clinical outcomes of long-term mechanical ventilation in patients with various respiratory diseases.
  • To identify patient subgroups that may benefit from chronic MV.

Main Methods:

  • Review of respiratory physiology and clinical data in patients undergoing long-term MV via tracheostomy or noninvasive ventilation.
  • Analysis of factors including patient-ventilator interaction, ventilation mode, and support levels.

Related Experiment Videos

Main Results:

  • Mechanical ventilation can lead to increased sensitivity to hypercapnia, improved blood gas tensions, and reduced pulmonary artery pressures.
  • Positive effects include augmented cardiac function and enhanced exercise tolerance in some patients.
  • Chronic MV may not improve pathophysiology or prognosis in patients with fibrotic lung disease or COPD.

Conclusions:

  • Careful consideration of ventilation mode, patient-ventilator interaction, and support is essential for managing patients on long-term MV.
  • While beneficial for some, long-term MV does not universally alter disease progression or prognosis.